3,000
Participants
Start Date
December 8, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Minimal documentation
Minimal data documentation only of patients without targeted therapy based on NGS results
Extended documentation
Extended data documentation of patients with targeted therapy based on NGS results
NOT_YET_RECRUITING
Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim
RECRUITING
Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg im Breisgau
NOT_YET_RECRUITING
Klinikum der Universität München, München
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY
Janssen-Cilag G.m.b.H
INDUSTRY
AIO-Studien-gGmbH
OTHER